Basic Information
-
Gene targeting strategy
-
Gene targeting strategy for B-NDG MGMT3 mice. The full sequences of mouse Il3, Csf2, Csf1, Thpo genes except the UTRs were respectively replaced with the coding sequences (CDS) of human IL3, CSF2, CSF1, THPO genes.
-
Protein expression analysis
-
Species-specific GM-CSF, CSF1 and THPO protein expression analysis in wild-type B-NDG and B-NDG MGMT3 mice. Following LPS stimulation in vivo, serum was collected from wild-type B-NDG (+/+) and homozygous B-NDG MGMT3 (H/H) mice and analyzed by ELISA (n=3) using species-specific kits. Murine GM-CSF, CSF1 and THPO proteins were detected in B-NDG mice, while human GM-CSF, CSF1 and THPO proteins were detected in B-NDG MGMT3 mice. Mouse and/or human IL3 protein expression was not detected in immunodeficient B-NDG and/or B-NDG MGMT3 mice due to the lack of mature (activated) T cells.
-
Human CD34+ HSC engraftment for human immune system reconstitution
-
Human CD34+ HSC engraftment for human immune system reconstitution. Wild-type B-NDG and B-NDG MGMT3 (both sex, 24-72 hr after birth, n=15) mice were engrafted with human CD34+ HSCs (3E4) by intravenous (temporal vein) injection. B-NDG mice were treated with 1.0 Gy-irradiation, while B-NDG MGMT3 mice were not irradiated. (A) Survival rates were analyzed by Kaplan Meier survival curves. (B) Body weight measurements. Results showed that the survival rate of B-NDG MGMT3 mice were similar to that of B-NDG mice until 16 weeks post human CD34+ HSC engraftment, while body weight of B-NDG MGMT3 mice was significantly higher than that of B-NDG mice. Values are expressed as mean ± SEM. HSCs: hematopoietic stem cells.
Human CD34+ HSC engraftment for human immune system reconstitution. Human CD34+ HSCs (3E4) were intravenous (temporal vein) engrafted into wild-type B-NDG mice and homozygous B-NDG MGMT3 mice (both sex, 24-72 hr after birth, n=15). B-NDG mice were treated with 1.0 Gy-irradiation. B-NDG MGMT3 mice were not irradiated. Peripheral blood lymphocytes from the two mice after engraftment with human CD34+ HSCs were analyzed with flow cytometry. Results showed that the proportion of CD45+ cells in B-NDG MGMT3 mice reached 25% starting from 12 weeks after engraftment and continued to rise, significantly higher than that in B-NDG mice. The proportions of monocytes, MDSCs, DCs and Tregs in B-NDG MGMT3 mice were higher than that in B-NDG mice. Values are expressed as mean ± SEM.
Human CD34+ HSC engraftment for human immune system reconstitution. Human CD34+ HSCs (3E4) were intravenous (temporal vein) engrafted into wild-type B-NDG mice and homozygous B-NDG MGMT3 mice (both sex, 24-72 hr after birth, n=15). B-NDG mice were treated with 1.0 Gy-irradiation. B-NDG MGMT3 mice were not irradiated. Peripheral blood lymphocytes from the two mice after engraftment with human CD34+ HSCs were analyzed with flow cytometry. Results showed that the cell numbers of all the cells analyzed from 12 weeks after engraftment in B-NDG MGMT3 mice were higher than that in B-NDG mice. Values are expressed as mean ± SEM. Values are expressed as mean ± SEM.
-
Poster
